Protalix Biotherapeutics(PLX)

HACKENSACK, NJ

Biotechnology

Focus: Plant-derived Recombinant Therapeutics

Protalix Biotherapeutics is a life sciences company focused on Plant-derived Recombinant Therapeutics.

Funding Stage

PUBLIC

Open Jobs

Open Jobs (1)

Interview Prep Quick Facts

Founded: 2024

SEC Filings: 2 available

Open Roles: 1 active job

Revenue

$48M24%

R&D Spend

$29M(62%)1%

Net Income

-$15M

Cash

$24M